Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-04 Purchase |
2020-12-07 5:14 pm |
Regulus Therapeutics Inc. | RGLS | Walker Paul Edward 10% Owner |
4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Indirect) |
View |
| 2020-12-04 Purchase |
2020-12-07 5:13 pm |
Regulus Therapeutics Inc. | RGLS | Sonsini Peter W. 10% Owner |
4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Indirect) |
View |
| 2020-12-04 Purchase |
2020-12-07 5:12 pm |
Regulus Therapeutics Inc. | RGLS | SANDELL SCOTT D 10% Owner |
4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Indirect) |
View |
| 2020-12-04 Purchase |
2020-12-07 5:12 pm |
Regulus Therapeutics Inc. | RGLS | MAKOWER JOSHUA 10% Owner |
4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Indirect) |
View |
| 2020-12-04 Purchase |
2020-12-07 5:11 pm |
Regulus Therapeutics Inc. | RGLS | Makhzoumi Mohamad 10% Owner |
4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Indirect) |
View |
| 2020-12-04 Purchase |
2020-12-07 5:10 pm |
Regulus Therapeutics Inc. | RGLS | Florence Anthony A. Jr. 10% Owner |
4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Indirect) |
View |
| 2020-12-04 Purchase |
2020-12-07 5:10 pm |
Regulus Therapeutics Inc. | RGLS | Chang Carmen 10% Owner |
4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Indirect) |
View |
| 2020-12-04 Purchase |
2020-12-07 5:09 pm |
Regulus Therapeutics Inc. | RGLS | Behbahani Ali 10% Owner |
4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Indirect) |
View |
| 2020-12-04 Purchase |
2020-12-07 5:08 pm |
Regulus Therapeutics Inc. | RGLS | BASKETT FOREST 10% Owner |
4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Indirect) |
View |
| 2020-12-04 Purchase |
2020-12-07 5:06 pm |
Regulus Therapeutics Inc. | RGLS | Growth Equity Opportunities V LLC New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner |
4,398,602 | $0.622 | $2,735,930 | 11,949,017 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 4:10 pm |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
876 | $0.5211 | $456 | 25,762 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 4:09 pm |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO |
6,094 | $0.5211 | $3,176 | 215,994 (Direct) |
View |
| 2020-08-14 Sale |
2020-08-17 8:22 pm |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO |
4,245 | $0.6049 | $2,568 | 222,088 (Direct) |
View |
| 2020-08-14 Sale |
2020-08-17 8:21 pm |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
872 | $0.605 | $528 | 26,638 (Direct) |
View |
| 2020-05-15 Sale |
2020-05-18 4:28 pm |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO |
4,426 | $0.6267 | $2,774 | 226,333 (Direct) |
View |
| 2020-05-15 Sale |
2020-05-18 4:27 pm |
Regulus Therapeutics Inc. | RGLS | Aker Christopher Ray Sr. VP & General Counsel |
909 | $0.6268 | $570 | 27,510 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-12-04 Option Award |
2020-12-07 4:22 pm |
2020-12-04 2025-12-04 |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO |
29,760 | $0.125 | 255,434 (Indirect) |
View |
| 2020-12-04 Option Award |
2020-12-07 4:22 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | Hagan Joseph P President and CEO |
39,680 | $0.6301 | 255,434 (Indirect) |
View |
| 2020-12-04 Option Award |
2020-12-07 4:21 pm |
2020-12-04 2025-12-04 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
595,146 | $0.125 | 2,581,875 (Direct) |
View |
| 2020-12-04 Option Award |
2020-12-07 4:21 pm |
N/A N/A |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
793,528 | $0.6301 | 2,581,875 (Direct) |
View |
| 2020-03-03 Option Award |
2020-08-05 09:12 am |
N/A 2030-08-02 |
Regulus Therapeutics Inc. | RGLS | Drygin Denis Chief Scientific Officer |
300,000 | $0 | 300,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:45 pm |
N/A 2030-06-16 |
Regulus Therapeutics Inc. | RGLS | Witz Pascale Director |
23,250 | $0 | 23,250 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:44 pm |
N/A 2030-06-16 |
Regulus Therapeutics Inc. | RGLS | Simeonidis Simos Director |
23,250 | $0 | 23,250 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:43 pm |
N/A 2030-06-16 |
Regulus Therapeutics Inc. | RGLS | Rosen Hugh Director |
23,250 | $0 | 23,250 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:42 pm |
N/A 2030-06-16 |
Regulus Therapeutics Inc. | RGLS | RASTETTER WILLIAM H Director |
23,250 | $0 | 23,250 (Indirect) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:40 pm |
N/A 2030-06-16 |
Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director |
23,250 | $0 | 23,250 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:39 pm |
N/A 2030-06-16 |
Regulus Therapeutics Inc. | RGLS | Nunn Jason Raleigh Director |
23,250 | $0 | 23,250 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:38 pm |
N/A 2030-06-16 |
Regulus Therapeutics Inc. | RGLS | Collier Kathryn J Director |
23,250 | $0 | 23,250 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-19 4:37 pm |
N/A 2030-06-16 |
Regulus Therapeutics Inc. | RGLS | BALTIMORE DAVID Director |
23,250 | $0 | 23,250 (Direct) |
View |